Obesity is associated with a slower response to initial phenprocoumon therapy whereas CYP2C9 genotypes are not - Meyer, C zu Schwabedissen; Mevissen, V; Schmitz, F; Woodruff, S; Langebartels, G; Rau, T; Zerres, K; Hoffmann, R; Ortlepp, JR (Eur J Clin Pharmacol, 2006)